A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).
The Liaoning Cancer Hospital & Institute is committed to providing exceptional service through their multidisciplinary care and clinical research.
Shenyang, China Clinical Trial Location
Liaoning Cancer Hospital & Institute
44 Xiaoheyan Rd, Dadong District,
Shenyang, Liaoning, China, 110042